NCT00367744View on ClinicalTrials.gov

Rosiglitazone Effect on Mitochondria and Lipoatrophy

PHASE2CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

HIV Infections

Interventions

DRUG

Rosiglitazone

Rosiglitazone 4mg BID

DRUG

Placebo

Placebo for rosiglitazone

Trial Locations (2)

44106

Cleveland Clinc Foundation, Cleveland

44141

University Hospitals of Cleveland/Case Western Reserve University, Cleveland

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH